Effects of FGFs on the morphogenic potency and AER-maintenance activity of cultured progress zone cells of chick limb bud.
The apical mesodermal region of chick limb buds (progress zone, PZ) which is essential for limb pattern formation contains uncommitted cells that change their positional values instructed by the apical ectodermal ridge (AER). Reciprically, the PZ cells maintain the AER activity. FGF-2 and FGF-4 can substitute for the AER to maintain normal outgrowth and gene expression in the limb bud. We examined the effects of FGF on the maintenance of PZ cells characteristics in culture by making recombinant limbs with anterior PZ cells that were pre-cultured in the presence of FGF-2 or FGF-4 and analyzed their morphogenic potency and responsiveness to positional cues arising from the zone of polarizing activity (ZPA). The limb buds expressed distal Hox genes and could form a segmented digit. Recombinant limb buds consisting of anterior PZ cells cultured without FGF failed to express Hox genes and formed instead a small cartilage nodule. These results indicate that addition of FGF-2 or FGF-4 to cultured PZ cells maintains their competence for Hox gene expression and digit formation, but not their responsiveness to positional cues from the ZPA. We also found that when anterior PZ cells which had been pre-cultured with FGF-2 or FGF-4 were implanted underneath the AER, they could maintain Fgf-8 expression in the AER, whereas this expression was not detected in the AER on the grafted anterior PZ cells that had been pre-cultured without FGF, indicating that FGF maintains AER-maintenance activity of PZ cells in culture.
Biological Institute, Tohoku University, Sendai, Japan. khara@virus.kyoto-u.ac.jp
K
K
Hara
J
J
Kimura
H
H
Ide
D000818:Animals; D019521:Body Patterning; D002356:Cartilage / Q000196:embryology; D017690:Cell Transplantation; D002478:Cells, Cultured; D002642:Chick Embryo; D004475:Ectoderm / Q000166:cytology / Q000502:physiology*; D004627:Embryonic Induction; D016222:Fibroblast Growth Factor 2 / Q000494:pharmacology*; D051519:Fibroblast Growth Factor 4; D051524:Fibroblast Growth Factor 8; D005346:Fibroblast Growth Factors / Q000235:genetics / Q000494:pharmacology*; D018507:Gene Expression Regulation, Developmental; D005801:Genes, Homeobox; D018398:Homeodomain Proteins / Q000235:genetics; D018878:Limb Buds / Q000166:cytology / Q000196:embryology*; D051957:MSX1 Transcription Factor; D008648:Mesoderm / Q000166:cytology* / Q000637:transplantation; D009024:Morphogenesis; D009924:Organ Culture Techniques / Q000379:methods; D011518:Proto-Oncogene Proteins / Q000494:pharmacology*; D014157:Transcription Factors
D051519:Fibroblast Growth Factor 4; D018398:Homeodomain Proteins; D051957:MSX1 Transcription Factor; D011518:Proto-Oncogene Proteins; D014157:Transcription Factors; D016222:Fibroblast Growth Factor 2; D051524:Fibroblast Growth Factor 8; D005346:Fibroblast Growth Factors